Lessee, Operating Lease, Liability, Undiscounted Excess Amount of BIO-TECHNE Corp from 30 Jun 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
BIO-TECHNE Corp quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Jun 2020 to 31 Dec 2025.
  • BIO-TECHNE Corp Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2025 was $15,653,000, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $15,653,000 -$2,762,000 -15% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $16,750,000 -$2,922,000 -15% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $17,807,000 -$2,649,000 -13% 30 Jun 2025 10-K 22 Aug 2025 2025 FY
Q1 2025 $17,670,000 -$4,342,000 -20% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $18,415,000 -$4,860,000 -21% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $19,672,000 -$4,350,000 -18% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $20,456,000 -$4,481,000 -18% 30 Jun 2024 10-K 22 Aug 2024 2024 FY
Q1 2024 $22,012,000 -$3,742,000 -15% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $23,275,000 +$1,862,000 +8.7% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $24,022,000 +$21,575,000 +882% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $24,937,000 +$12,716,000 +104% 30 Jun 2023 10-K 23 Aug 2023 2023 FY
Q1 2023 $25,754,000 +$15,682,000 +156% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $21,413,000 +$11,179,000 +109% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $2,447,000 -$10,010,000 -80% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $12,221,000 -$1,343,000 -9.9% 30 Jun 2022 10-K 24 Aug 2022 2022 FY
Q1 2022 $10,072,000 -$5,439,000 -35% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $10,234,000 -$4,526,000 -31% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $12,457,000 -$3,020,000 -20% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $13,564,000 -$2,673,000 -16% 30 Jun 2021 10-K 25 Aug 2021 2021 FY
Q1 2021 $15,511,000 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $14,760,000 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $15,477,000 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $16,237,000 30 Jun 2020 10-K 26 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.